TELOMERE LOSS IN PH - NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS: THE ROLE OF JAK2 V617F MUTATION ALLELE BURDEN AND THE INFLUENCE OF THE HISTORY OF THE ILLNESS

被引：0

作者：

Ruella, M. ^{[1
]}

Salmoiraghi, S. ^{[2
]}

Risso, A.

Carobbio, A. ^{[2
]}

Sivera, P. ^{[3
]}

Mezzabotta, M. ^{[3
]}

Ricca, I. ^{[4
]}

Barbui, T. ^{[2
]}

Tarella, C. ^{[3
]}

Rambaldi, A. ^{[2
]}

机构：

[1] Univ Turin, Turin, Italy

[2] Ospedali Riuniti Bergamo, Bergamo, Italy

[3] ASO Mauriziano, Turin, Italy

[4] AO Cottolengo, Turin, Italy

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0403

引用

页码：164 / 164

页数：1

共 50 条

[21] RELATIONSHIP BETWEEN JAK2 V617F MUTATION WITH HEMATOLOGIC AND COAGULATION PARAMETERS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Urrechaga, Eloisa
Fernandez, Monica
Mugertza, Garazi
Ponga, Cristina
Naharro, Imanol
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 119 - 120
[22] JAK2 V617F ALLELE BURDEN AND VASCULAR COMPLICATION OCCURRENCE RISK IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Borowczyk, M.
Lewandowski, K.
Wojtaszewska, M.
Gil, L.
Lewandowska, M.
Lehmann-Kopydlowska, A.
Kroll-Balcerzak, R.
Balcerzak, A.
Iwola, M.
Michalak, M.
Komarnicki, M.
HAEMATOLOGICA, 2014, 99 : 129 - 129
[23] JAK2 (V617F) mutation burden, phenotype, and clinical course of chronic myeloproliferative disorders
Passamonti, F.
Rumi, E.
Pietra, D.
Della Porta, M. G.
Boveri, E.
Elena, C.
Boggi, S.
Arcaini, L.
Pascutto, C.
Lazzarino, M.
Cazzola, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 243 - 243
[24] JAK2 V617F MUTATION IN ACUTE MYELOID LEUKEMIA SECONDARY TO PH NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS
Rinaldi, C. R.
Rinaldi, P.
Martinelli, V.
Ciancia, R.
Gugliotta, L.
Vannucchi, A. M.
Barbui, T.
Rotoli, B.
Pane, F.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : S28 - S28
[25] JAK2 V617F Allele Burden in Non-CML Classical Subtypes of Myeloproliferative Neoplasms (MPN)
Gober-Wilcox, J.
Vennapusa, B.
Pierce, J.
Vasef, M. A.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 581 - 581
[26] Evaluation of V617F mutation of JAK2 in negative chromosome Philadelphia chronic myeloproliferative disorders
Remacha, Angel F.
Puget, Guiomar
Nomdedeu, Josep F.
Estivill, Camino
Pilar Sarda, M.
Canals, Carme
MEDICINA CLINICA, 2006, 127 (16): : 601 - 604
[27] DOES ALLELE BURDEN IMPORT IN MYELOFIBROSIS WITH JAK2 V617F MUTATION?
Maria Isabel, Montero Cuadrado
Francisco Jose, Marquez Malaver
Cruz Estrella, Carrillo
Canale Silvia, Garcia
Lucia, Mezquita
Javier, Delgado
Caro Rocio, Marin
Francisco Jose, Martin Dominguez
Nancy, Rodriguez
Campos Jose, Gonzalez
Jose Francisco, Falantes
Jose Antonio, Perez Simon
HAEMATOLOGICA, 2021, 106 (10) : 258 - 258
[28] Telomere Length In Ph - Negative Chronic Myeloproliferative Neoplasms: It Is Reduced According to JAK2V617F Mutation Allele Burden and It Is Not Affected by Cytoreductive Treatment with Hydroxyurea
Ruella, Marco
Salmoiraghi, Silvia
Risso, Alessandra
Carobbio, Alessandra
Sivera, Piera
Ricca, Irene
Barbui, Tiziano
Tarella, Corrado
Rambaldi, Alessandro
BLOOD, 2010, 116 (21) : 825 - 825
[29] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
Jones, AV
Kreil, S
Zoi, K
Waghorn, K
Curtis, C
Zhang, LY
Score, J
Seear, R
Chase, AJ
Grand, FH
White, H
Zoi, C
Loukopoulos, D
Terpos, E
Vervessou, EC
Schultheis, B
Emig, M
Ernst, T
Lengfelder, E
Hehlmann, R
Hochhaus, A
Oscier, D
Silver, RT
Reiter, A
Cross, NCP
BLOOD, 2005, 106 (06) : 2162 - 2168
[30] Relation between JAK2 V617F mutation and chronic myeloproliferative disorders
Xiao, Zhjian
Zhang, Yue
Wang, Jianxiang
Hao, Yushu
BLOOD, 2007, 110 (11) : 233B - 233B

← 1 2 3 4 5 →